Cardiovascular Disease Progression: A Target for Therapy?

Area of Science:

• Cardiology
• Preventive Medicine
• Medical Diagnostics

Background:

• Clinical research for cardiovascular disease prevention primarily targets risk factors.
• Disease progression, a precursor to morbid events, is often overlooked as a therapeutic target.

Purpose of the Study:

• To evaluate the utility of a comprehensive noninvasive cardiovascular assessment in individuals without prior cardiovascular disease.
• To explore the relationship between a composite Disease Score and the risk of future cardiovascular events.

Main Methods:

• Conducted a noninvasive cardiovascular evaluation over 1 hour in a single setting.
• Assessed functional and structural abnormalities in small arteries, large arteries, and the left ventricle.
• Calculated a Disease Score based on the sum of abnormal test results.

Main Results:

• Preliminary follow-up data show a significant correlation between the Disease Score and the incidence of future morbid events.
• The comprehensive assessment provides a detailed view of cardiovascular abnormalities in asymptomatic individuals.

Conclusions:

• Focusing on slowing cardiovascular disease progression in early stages is crucial for prolonging disease-free life expectancy.
• Noninvasive assessments can identify individuals at risk and guide therapeutic strategies.